| Abstract
Background: Polycystic ovary syndrome (PCOS), as the most common endocrine disorder in reproductive-aged
women, is characterized by oxidative stress and ovarian tissue infammation. Green tea extract (GTE) potentially pos‑
sesses therapeutic efects for PCOS because of the antioxidant and anti-infammatory compounds. This systematic
review evaluates the potential roles of GTE on metabolic variables, hormone levels, and ovarian function in PCOS.
Methods: A systematic review was conducted of published studies reporting the efects of GTE on PCOS. Several
major databases, including PubMed, SCOPUS, and Google Scholar, were searched up from inception to April 2021.
Clinical trials and animal studies that assessed the efects of GTE on PCOS were eligible for inclusion.
Results: Of 314 articles found in the search, four human studies and four animal studies were included. All studies
in humans showed the efects of GTE on weight loss. GTE’s efect on decreasing testosterone levels in humans and
LH levels in animals were also reported. In addition, increases in FSH and progesterone levels in animal models were
observed. Although GTE improved fasting blood sugar and insulin levels, the efect of GTE on infammatory param‑
eters, such as TNF-alpha and IL-6 and antioxidant status, was limited to animal studies.
Conclusion: Therefore, this review suggests that GTE could be considered a potential agent to attenuate PCOS com‑
plications mainly due to its efect on weight loss and glycemic c levels. However, more studies are needed to formulate
conclusions about the efects and mechanisms of GTE in PCOS. |